In the world of inhalation APIs, precision is not just an advantage rather a huge necessity. The effectiveness of inhalation therapies relies heavily on how well the drug particles are engineered for deep lung delivery. At Coral Drugs, we understand this critical requirement and specialize in manufacturing Fluticasone Propionate with absolute precision to deliver consistent therapeutic outcomes.

Why Particle Size Matters

For inhalation drugs, the size of each particle makes the difference between effective treatment and wasted dose. Fluticasone Propionate which is a corticosteroid used widely for asthma and chronic obstructive pulmonary disease (COPD), requires precise particle engineering to reach the deep lung regions where it can act most effectively.

At Coral Drugs, our Micronization Process ensures that particles fall within the aerodynamic size range of 1 to 5 microns. This level of control allows:

• Deep lung deposition for maximum efficacy.
• Optimal anti-inflammatory action to reduce airway inflammation.
• Reliable therapeutic outcomes that patients and healthcare providers can trust.

This precise particle engineering is the cornerstone of our approach, bridging the gap between innovation and patient care.

Coral’s In-House Micronization

Our in-house Micronization capabilities are designed to maintain uniformity and consistency in every batch. By controlling critical parameters, we deliver Fluticasone Propionate that meets the rigorous standards required for both Dry Powder Inhaler (DPI) and Metered Dose Inhaler (MDI) formulations.

Key benefits of our Micronization include:

• Aerodynamic particle size control (1–5 microns).
• High batch-to-batch uniformity.
• Consistent accuracy that results in increased efficacy for enhanced patient outcomes.
• Regulatory-grade purity for global compliance.

With these capabilities, Coral Drugs stands as a trusted partner for companies seeking reliable inhalation APIs.

Trusted for Inhalation Therapies

Our strength lies not only in technology but also in our fully backward-integrated operations. This integration ensures that every step, from raw material sourcing to final API production, is monitored under stringent quality standards. Combined with cGMP-compliant processes, our production systems guarantee scalability without compromising on quality.

By investing in innovation, quality-driven practices, and advanced particle engineering, we ensure that Fluticasone Propionate manufactured by Coral Drugs supports effective, safe, and reliable inhalation therapies worldwide.

Commitment to Quality and Innovation

The landscape of inhalation therapies is evolving rapidly, with patients and healthcare providers demanding greater consistency, safety, and therapeutic precision. Coral Drugs is committed to meeting these demands through continuous research, innovation, and quality improvements in API manufacturing.

Our dedicated teams ensure that every product not only meets international standards but also exceeds expectations when it comes to reliability and therapeutic effectiveness. By focusing on precision in every particle, we help transform treatments into outcomes that truly make a difference.

Partner with Coral Drugs

At Coral Drugs, we believe in building strong partnerships across the pharmaceutical industry. Whether you are seeking a reliable source for Fluticasone Propionate or exploring new opportunities in inhalation APIs, our team is ready to collaborate with you.

For updates, innovations, and insights stay connected with us on our LinkedIn 

‍